BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Purdue Pharma L.P. (Connecticut) 

Headquarters
One Stamford Forum
Stamford  Connecticut  06901-3431  U.S.A.
Phone: 203-588-8000 Fax: 203-588-8850


SEARCH JOBS

View Clinical Trials from BioPharm Insight

Purdue Pharma L.P., headquartered in Stamford, CT, is a privately held pharmaceutical company founded by physicians and focused on meeting the needs of healthcare providers and the patients in their care. Together with its independent associated companies, Purdue is dedicated to finding, developing, and bringing to market new medicines and related products that improve health outcomes. The company has long been known for its pioneering research on persistent pain, a principal cause of human suffering.

Purdue also has a growing line of non-prescription products including laxatives, microbicides, and nutraceuticals. The company is dedicated to serving the evolving needs of healthcare providers, patients, and caregivers with prescription and non-prescription medicines. A commitment to innovation and caring spans every aspect of the organization, from discovering and launching new medicines to demonstrating their medical value.

Purdue has led the battle against inadequate treatment of pain by developing sustained-release medications to manage pain. Its sales, marketing, and medical education professionals provide the healthcare community with comprehensive educational materials and programs relating to pain management.

In 1993, Purdue established Partners Against Pain® as a resource to help patients, caregivers, and healthcare professionals advance standards of pain care and alleviate unnecessary suffering through education and advocacy. Purdue has also assumed a leading role in addressing the serious public health problem of prescription drug abuse, supporting programs intended to help stem abuse.

At its research facilities in Cranbury, New Jersey, Purdue scientists are discovering new compounds to treat pain and developing formulations and delivery systems to help improve patient safety.

 Key Statistics


Email:
Ownership:

Web Site: Purdue Pharma L.P.
Employees: 1,650
Symbol: 
 



Industry
Pharmaceutical






 Company News
Purdue Pharma L.P. Receives FDA Approval For 7.5 Mcg/Hour Dosage Strength Of Butrans® (Buprenorphine) Transdermal System CIII 7/16/2014 9:21:44 AM
Purdue Pharma L.P. To Lay Off Staffers At Its Headquarters In Stamford 6/26/2014 6:25:46 AM
Purdue Pharma L.P. Reorganizes And Cuts One-Third Of R&D 6/18/2014 10:50:42 AM
California Counties Sue Drugmakers Actavis (ACT), Endo Pharmaceuticals (ENDP), Johnson & Johnson (JNJ), Purdue Pharma L.P. And Teva Pharmaceutical Industries Limited (TEVA) Over Painkiller Abuse 5/27/2014 8:32:33 AM
Purdue Pharma L.P. Names Saeed Motahari Senior Vice President and Chief Commercial Officer 5/22/2014 6:53:53 AM
Zogenix, Inc. (ZGNX) Falls As Rival Purdue Pharma L.P. Announces Positive Phase 3 Trial Of Abuse-Resistant Pill 3/12/2014 7:14:26 AM
Jobs Cut As Purdue Pharma L.P. Restructures 2/17/2014 7:43:36 AM
Purdue Pharma L.P. Names Mark Timney President And Chief Executive Officer 1/27/2014 6:44:41 AM
Purdue Pharma L.P. Announces Resolution Of OxyContin® (Oxycodone HCl Controlled-Release) Tablets CII Patent Lawsuit With IMPAX Laboratories, Inc. (IPXL) 12/3/2013 11:46:13 AM
FDA Accepts For Review Purdue Pharma L.P.'s New Drug Application For Targiniq™ ER (oxycodone HCl/naloxone HCL Controlled-Release) Tablets CII 11/26/2013 8:49:24 AM
123456789